254 related articles for article (PubMed ID: 16781058)
1. Establishment of specific antibodies that recognize C106-oxidized DJ-1.
Ooe H; Iguchi-Ariga SM; Ariga H
Neurosci Lett; 2006 Aug; 404(1-2):166-9. PubMed ID: 16781058
[TBL] [Abstract][Full Text] [Related]
2. Preparation and application of monoclonal antibodies against oxidized DJ-1. Significant elevation of oxidized DJ-1 in erythrocytes of early-stage Parkinson disease patients.
Saito Y; Hamakubo T; Yoshida Y; Ogawa Y; Hara Y; Fujimura H; Imai Y; Iwanari H; Mochizuki Y; Shichiri M; Nishio K; Kinumi T; Noguchi N; Kodama T; Niki E
Neurosci Lett; 2009 Nov; 465(1):1-5. PubMed ID: 19733211
[TBL] [Abstract][Full Text] [Related]
3. DJ-1, a causative gene product of a familial form of Parkinson's disease, is secreted through microdomains.
Tsuboi Y; Munemoto H; Ishikawa S; Matsumoto K; Iguchi-Ariga SM; Ariga H
FEBS Lett; 2008 Jul; 582(17):2643-9. PubMed ID: 18586035
[TBL] [Abstract][Full Text] [Related]
4. Separation of native and C106-oxidized DJ-1 proteins by using column chromatography.
Choi J; Yoo HJ; Cho K; Kim HN; Lee JH; Ryu KS
Protein Expr Purif; 2022 Aug; 195-196():106092. PubMed ID: 35430350
[TBL] [Abstract][Full Text] [Related]
5. Secretion of DJ-1 into the serum of patients with Parkinson's disease.
Maita C; Tsuji S; Yabe I; Hamada S; Ogata A; Maita H; Iguchi-Ariga SM; Sasaki H; Ariga H
Neurosci Lett; 2008 Jan; 431(1):86-9. PubMed ID: 18162323
[TBL] [Abstract][Full Text] [Related]
6. Specific cleavage of DJ-1 under an oxidative condition.
Ooe H; Maita C; Maita H; Iguchi-Ariga SM; Ariga H
Neurosci Lett; 2006 Oct; 406(3):165-8. PubMed ID: 16935423
[TBL] [Abstract][Full Text] [Related]
7. Destabilization of DJ-1 by familial substitution and oxidative modifications: implications for Parkinson's disease.
Hulleman JD; Mirzaei H; Guigard E; Taylor KL; Ray SS; Kay CM; Regnier FE; Rochet JC
Biochemistry; 2007 May; 46(19):5776-89. PubMed ID: 17451229
[TBL] [Abstract][Full Text] [Related]
8. Oxidized DJ-1 inhibits p53 by sequestering p53 from promoters in a DNA-binding affinity-dependent manner.
Kato I; Maita H; Takahashi-Niki K; Saito Y; Noguchi N; Iguchi-Ariga SM; Ariga H
Mol Cell Biol; 2013 Jan; 33(2):340-59. PubMed ID: 23149933
[TBL] [Abstract][Full Text] [Related]
9. DJ-1 binds to mitochondrial complex I and maintains its activity.
Hayashi T; Ishimori C; Takahashi-Niki K; Taira T; Kim YC; Maita H; Maita C; Ariga H; Iguchi-Ariga SM
Biochem Biophys Res Commun; 2009 Dec; 390(3):667-72. PubMed ID: 19822128
[TBL] [Abstract][Full Text] [Related]
10. DJ-1-binding compounds prevent oxidative stress-induced cell death and movement defect in Parkinson's disease model rats.
Miyazaki S; Yanagida T; Nunome K; Ishikawa S; Inden M; Kitamura Y; Nakagawa S; Taira T; Hirota K; Niwa M; Iguchi-Ariga SM; Ariga H
J Neurochem; 2008 Jun; 105(6):2418-34. PubMed ID: 18373560
[TBL] [Abstract][Full Text] [Related]
11. Monomer DJ-1 and its N-terminal sequence are necessary for mitochondrial localization of DJ-1 mutants.
Maita C; Maita H; Iguchi-Ariga SM; Ariga H
PLoS One; 2013; 8(1):e54087. PubMed ID: 23326576
[TBL] [Abstract][Full Text] [Related]
12. Effect of single amino acid substitution on oxidative modifications of the Parkinson's disease-related protein, DJ-1.
Madian AG; Hindupur J; Hulleman JD; Diaz-Maldonado N; Mishra VR; Guigard E; Kay CM; Rochet JC; Regnier FE
Mol Cell Proteomics; 2012 Feb; 11(2):M111.010892. PubMed ID: 22104028
[TBL] [Abstract][Full Text] [Related]
13. Loss of the Parkinson's disease-linked gene DJ-1 perturbs mitochondrial dynamics.
Irrcher I; Aleyasin H; Seifert EL; Hewitt SJ; Chhabra S; Phillips M; Lutz AK; Rousseaux MW; Bevilacqua L; Jahani-Asl A; Callaghan S; MacLaurin JG; Winklhofer KF; Rizzu P; Rippstein P; Kim RH; Chen CX; Fon EA; Slack RS; Harper ME; McBride HM; Mak TW; Park DS
Hum Mol Genet; 2010 Oct; 19(19):3734-46. PubMed ID: 20639397
[TBL] [Abstract][Full Text] [Related]
14. Cysteine pKa depression by a protonated glutamic acid in human DJ-1.
Witt AC; Lakshminarasimhan M; Remington BC; Hasim S; Pozharski E; Wilson MA
Biochemistry; 2008 Jul; 47(28):7430-40. PubMed ID: 18570440
[TBL] [Abstract][Full Text] [Related]
15. DJ-1/PARK7: A New Therapeutic Target for Neurodegenerative Disorders.
Hijioka M; Inden M; Yanagisawa D; Kitamura Y
Biol Pharm Bull; 2017; 40(5):548-552. PubMed ID: 28458339
[TBL] [Abstract][Full Text] [Related]
16. DJ-1 and prevention of oxidative stress in Parkinson's disease and other age-related disorders.
Kahle PJ; Waak J; Gasser T
Free Radic Biol Med; 2009 Nov; 47(10):1354-61. PubMed ID: 19686841
[TBL] [Abstract][Full Text] [Related]
17. DJ-1 as a Biomarker of Parkinson's Disease.
Saito Y
Adv Exp Med Biol; 2017; 1037():149-171. PubMed ID: 29147908
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective function of DJ-1 in Parkinson's disease.
Ariga H; Takahashi-Niki K; Kato I; Maita H; Niki T; Iguchi-Ariga SM
Oxid Med Cell Longev; 2013; 2013():683920. PubMed ID: 23766857
[TBL] [Abstract][Full Text] [Related]
19. Elevation of oxidized DJ-1 in the brain and erythrocytes of Parkinson disease model animals.
Akazawa YO; Saito Y; Hamakubo T; Masuo Y; Yoshida Y; Nishio K; Shichiri M; Miyasaka T; Iwanari H; Mochizuki Y; Kodama T; Noguchi N; Niki E
Neurosci Lett; 2010 Oct; 483(3):201-5. PubMed ID: 20708070
[TBL] [Abstract][Full Text] [Related]
20. PARK7 DJ-1 protects against degeneration of nigral dopaminergic neurons in Parkinson's disease rat model.
Inden M; Taira T; Kitamura Y; Yanagida T; Tsuchiya D; Takata K; Yanagisawa D; Nishimura K; Taniguchi T; Kiso Y; Yoshimoto K; Agatsuma T; Koide-Yoshida S; Iguchi-Ariga SM; Shimohama S; Ariga H
Neurobiol Dis; 2006 Oct; 24(1):144-58. PubMed ID: 16860563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
